Cargando…

Monitoring the Dynamics of T Cell Clonal Diversity Using Recombinant Peptide:MHC Technology

The capacity to probe antigen specific T cells within the polyclonal repertoire has been revolutionized by the advent of recombinant peptide:MHC (pMHC) technology. Monomers and multimers of pMHC molecules can enrich for and identify antigen specific T cells to elucidate the contributions of T cell f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanchfield, J. Lori, Shorter, Shayla K., Evavold, Brian D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699728/ https://www.ncbi.nlm.nih.gov/pubmed/23840195 http://dx.doi.org/10.3389/fimmu.2013.00170

Ejemplares similares

Trans-Allelic Model for Prediction of Peptide:MHC-II Interactions
por: Degoot, Abdoelnaser M., et al.
Publicado: (2018)

Computationally profiling peptide:MHC recognition by T-cell receptors and T-cell receptor-mimetic antibodies
por: Raybould, Matthew I. J., et al.
Publicado: (2023)

Derivation of an amino acid similarity matrix for peptide:MHC binding and its application as a Bayesian prior
por: Kim, Yohan, et al.
Publicado: (2009)

Dynamically Driven Allostery in MHC Proteins: Peptide-Dependent Tuning of Class I MHC Global Flexibility
por: Ayres, Cory M., et al.
Publicado: (2019)

Proofreading of Peptide—MHC Complexes through Dynamic Multivalent Interactions
por: Thomas, Christoph, et al.
Publicado: (2017)

Peptide and Peptide-Dependent Motions in MHC Proteins: Immunological Implications and Biophysical Underpinnings
por: Ayres, Cory M., et al.
Publicado: (2017)

Specific MHC-I Peptides Are Induced Using PROTACs
por: Jensen, Stephanie M., et al.
Publicado: (2018)

Estimating the Diversity, Completeness, and Cross-Reactivity of the T Cell Repertoire
por: Zarnitsyna, Veronika I., et al.
Publicado: (2013)

High prevalence of low affinity peptide–MHC II tetramer–negative effectors during polyclonal CD4(+) T cell responses
por: Sabatino, Joseph J., et al.
Publicado: (2011)

Regulation of MHC Class II-Peptide Complex Expression by Ubiquitination
por: Cho, Kyung-Jin, et al.
Publicado: (2013)

Effects of Peptide on NK Cell-Mediated MHC I Recognition
por: Cassidy, Sorcha A., et al.
Publicado: (2014)

Physicochemical Heuristics for Identifying High Fidelity, Near-Native Structural Models of Peptide/MHC Complexes
por: Keller, Grant L. J., et al.
Publicado: (2022)

Viral Escape Mutant Epitope Maintains TCR Affinity for Antigen yet Curtails CD8 T Cell Responses
por: Shorter, Shayla K., et al.
Publicado: (2016)

Optimized Peptide–MHC Multimer Protocols for Detection and Isolation of Autoimmune T-Cells
por: Dolton, Garry, et al.
Publicado: (2018)

A Missing Switch in Peptide Exchange for MHC Class II Molecules
por: Freund, Christian, et al.
Publicado: (2019)

Peptide-MHC-Based Nanomedicines for the Treatment of Autoimmunity: Engineering, Mechanisms, and Diseases
por: Serra, Pau, et al.
Publicado: (2021)

Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP
por: Vijver, Saskia V., et al.
Publicado: (2023)

Thermodynamics of Peptide-MHC Class II Interactions: Not all Complexes are Created Equal
por: Ferrante, Andrea
Publicado: (2013)

Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100
por: Tse, Kevin, et al.
Publicado: (2013)

From Chickens to Humans: The Importance of Peptide Repertoires for MHC Class I Alleles
por: Kaufman, Jim
Publicado: (2020)

MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response
por: Tagliamonte, Maria, et al.
Publicado: (2021)

PANDORA: A Fast, Anchor-Restrained Modelling Protocol for Peptide: MHC Complexes
por: Marzella, Dario F., et al.
Publicado: (2022)

HLA-DM catalytically enhances peptide dissociation by sensing peptide–MHC class II interactions throughout the peptide-binding cleft
por: Reyes-Vargas, Eduardo, et al.
Publicado: (2020)

Integrating Experiment and Theory to Understand TCR-pMHC Dynamics
por: Buckle, Ashley M., et al.
Publicado: (2018)

Mechanistic diversity in MHC class I antigen recognition
por: Barbosa, Camila R. R., et al.
Publicado: (2021)

Lower Affinity T Cells are Critical Components and Active Participants of the Immune Response
por: Martinez, Ryan J., et al.
Publicado: (2015)

An effective peptide vaccine strategy circumventing clonal MHC heterogeneity of murine myeloid leukaemia
por: Shin, A-Ri, et al.
Publicado: (2020)

Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope
por: Cole, David K., et al.
Publicado: (2017)

The Repertoires of Peptides Presented by MHC-II in the Thymus and in Peripheral Tissue: A Clue for Autoimmunity?
por: Collado, Javier A., et al.
Publicado: (2013)

Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding
por: Chappell, Paul E, et al.
Publicado: (2015)

Integrating “omics” Technologies to Conceptualize Dynamic Antimicrobial Peptide Responses
por: Plichta, Jennifer K., et al.
Publicado: (2012)

Can Selective MHC Downregulation Explain the Specificity and Genetic Diversity of NK Cell Receptors?
por: Carrillo-Bustamante, Paola, et al.
Publicado: (2015)

Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules
por: Papadaki, Georgia F., et al.
Publicado: (2023)

The MHC Associated Peptide Proteomics assay is a useful tool for the non-clinical assessment of immunogenicity
por: Jankowski, Wojciech, et al.
Publicado: (2023)

Cytokine-Neuroantigen Fusion Proteins as a New Class of Tolerogenic, Therapeutic Vaccines for Treatment of Inflammatory Demyelinating Disease in Rodent Models of Multiple Sclerosis
por: Mannie, Mark D., et al.
Publicado: (2012)

Commentary: “Can Selective MHC Downregulation Explain the Specificity and Genetic Diversity of NK Cell Receptors?”
por: Robert, Philippe A.
Publicado: (2015)

Differential recombination dynamics within the MHC of macaque species
por: de Groot, Nanine, et al.
Publicado: (2014)

Conformation-selective rather than avidity-based binding to tumor associated antigen derived peptide-MHC enables targeting of WT1-pMHC low expressing cancer cells by anti-WT1-pMHC/CD3 T cell engagers
por: Walseng, Even, et al.
Publicado: (2023)

A Mechanistic Model for Predicting Cell Surface Presentation of Competing Peptides by MHC Class I Molecules
por: Boulanger, Denise S. M., et al.
Publicado: (2018)

New vistas unfold: Chicken MHC molecules reveal unexpected ways to present peptides to the immune system
por: Halabi, Samer, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_570u05n49fibsb957s29e9ruvo